Statement Of Changes In Equity [Abstract]

Egetis Therapeutics - Filing #5995613

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Purchase of treasury shares
- SEK
15,000,000 SEK
15,000,000 SEK
- SEK
- SEK
Share issue related cost
- SEK
188,000,000 SEK
- SEK
188,000,000 SEK
- SEK
- SEK
263,000,000 SEK
263,000,000 SEK
- SEK
- SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.